Gloucester Pharmaceuticals gloucesterpharma.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Gloucester Pharmaceuticals is developing a late-stage clinical compound for T-cell lymphomas and other malignancies.

Gloucester Pharmaceuticals is developing a late-stage clinical compound for T-cell lymphomas and other malignancies.

Company (Acquired)

Phone: 617-583-1300

Fax:

One Broadway
14th Floor
Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gloucester Pharmaceuticals $58M Jan 11, 2010
Stemina Biomarker Discovery $16M Jun 7, 2016
KAI Pharmaceuticals $63M Apr 11, 2012
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gloucester Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)